- In May 2023, dsm-firmenich unveiled Maxilact Next, promoted as the fastest-acting pure lactase enzyme available in the market, designed to improve the production efficiency of lactose-free dairy products. This launch strengthens the company’s leadership in high-performance enzyme solutions catering to the growing lactose-free dairy demand
- In June 2022, Koninklijke DSM N.V. (Netherlands) announced its merger with Firmenich (Denmark), a global leader in fragrance and flavor innovation, aiming to enhance its market presence in nutrition, wellness, and beauty segments. This strategic merger, expected to be completed by 2023, positions the company to expand its capabilities across the lactase enzyme and broader ingredient markets
- In February 2022, Kerry Group plc. (Ireland) completed the acquisition of c-LEcta (Germany), a biotechnology innovator specializing in enzyme production through precision fermentation and bioprocessing. This acquisition is expected to accelerate Kerry’s entry and growth in the global lactase enzyme market
- In November 2021, Chr. Hansen Holding A/S (Denmark) introduced Sweety Y-3, a next-generation enzyme solution that reduces added sugar in yogurt while enhancing its natural sweetness without compromising product quality. This launch strengthens the company’s position in the lactase enzyme market and aligns with the growing demand for healthier dairy alternatives
- In June 2021, IFF rolled out an innovative lactase enzyme developed specifically for milk and neutral dairy products to help North American dairy manufacturers meet rising consumer demand for lactose-free offerings. This product launch reinforces IFF’s commitment to supporting the evolving needs of the dairy industry
